WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,043 Cr | ₹2,791 Cr | ₹3,435 Cr | ₹3,207 Cr | ₹3,121 Cr |
What is the latest Total Current Liabilities ratio of WOCKHARDT ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,043 Cr |
| Mar2024 | ₹2,791 Cr |
| Mar2023 | ₹3,435 Cr |
| Mar2022 | ₹3,207 Cr |
| Mar2021 | ₹3,121 Cr |
How is Total Current Liabilities of WOCKHARDT Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,043 Cr | -26.80 | |
| Mar2024 | ₹2,791 Cr | -18.75 | |
| Mar2023 | ₹3,435 Cr | 7.11 | |
| Mar2022 | ₹3,207 Cr | 2.76 | |
| Mar2021 | ₹3,121 Cr | - | |
Compare Total Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹23,164.4 Cr | -1.1% | 21.1% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -1.1% |
21.1% |
0.1% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses